Similar evidence has been provided by other research groups, associating overexpression of CD36 with shorter survival of melanoma patients with tumor-infiltrating CD8+ T cells, while CD36-depleted CD8+ T cells showed greater antitumor potential and survival compared with wild-type CD8+ T cells [77–80]. This evidence concerns the gene CD8A and melanoma.